Table 1.
Pharmacological studies using different methodologies of inhalation cough challenge with citric acid or tartaric acid* as tussigenic agents.
Author | Delivery system | Output (O) or volume (V) | Inh type | Dose or concentration | Recording method | Normal values | Agent tested | Number tested |
---|---|---|---|---|---|---|---|---|
Lowry et al. [70, 100] | Neb (U) | 1.8 ml min−1 (O) | 1 min | 0.68% in 0.79% NaCl | 1 min | 11.4 coughs min−1 [100] | Captopril [70] | 21 [100] 16 [70] |
Poundsford et al. [47, 63, 101] | Neb | 833 ml (V) | 5 s | 0.5–32% [101] 0.125–2.0 × 10−1 mol l−1 [63] | C-Thresh [63] CI [101] | Total coughs and CI: 11.6 and 5.3 [101] | Salbutamol, ipratropium [101] Opiates [63] | 16 [101] |
Laude et al. [24] | Neb + d-meter | 0.125 ml Inh−1 (O) | S-breath | 10–1000.0 mm | 10 s | D5 141.3 mm Capsaicin | Citric acid | 10 |
Fujimura et al. [46, 60, 61] | Neb | 0.21 ml min−1 (O) | 15 s | 1.56–800.0 mg ml−1 | 1 min | Geomean D5 1.03 mg l−1 (F) 2.62 mg l−1 (M) [61] 32.0 mg ml−1 [46, 60] | Mexiletine [60] Procaterol Methacholine [46] | 14 [60] 28 [46] |
Thompson et al. [30, 31] | Neb + d-meter | 0.275 ml Inh−1 (O) | S-breath | 500.0 mm | 10 s | 19.07 coughs (F) 11.97 coughs (M) [30] | Dextromethorphan dextrorphan [31] | 160 [30] 19 [31] |
Packman et al. [34] | – | – | S-breath | 5% | 1 min | – | Diphenhydramine | 20 |
Morice et al. [32, 33] | Neb + d-meter | 0.125 ml Inh−1 (O) | S-breath | 33.0 µmol | 1-min | 9 coughs (baseline) [32] | Menthol [32] dextromethorphan [33] | 20 [32] |
Neb = Nebulizer (Jet unless stated otherwise), U = Ultrasonic, d-meter = Breath activated dosimeter, Inh = Inhalation, S-breath = Single breath, MMD = Mass median diameter, MMAD = Mass median aerodynamic diameter, CI = Cough index, i.e. number of coughs divided by the time of coughing, C-Thresh = Cough threshold, i.e. concentration causing one cough, Geomean = Geometric mean, ACEI = Angiotensin converting enzyme inhibitors.